Based on the provided information, you can state that tinzaparin is generally considered non-inferior to VKAs and shows a possible trend toward reduced recurrence of VTE in certain patient populations, particularly those with cancer.
← all excerpts
The Crucial Role of Tinzaparin in Managing Venous Thromboembolism in the Cancer Population.
1
—
—